[HTML] plos.org

[HTML][HTML] Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review

RA Mahumud, K Alam, SA Keramat, GM Ormsby… - PloS one, 2020 - journals.plos.org
Introduction The World Health Organization (WHO) recommends that human papillomavirus
(HPV) vaccination programs are established to be cost-effective before implementation …
被引用次数：29 相关文章

Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review

RA Mahumud, K Alam, SA Keramat… - PloS …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction The World Health Organization (WHO) recommends that human papillomavirus
(HPV) vaccination programs are established to be cost-effective before implementation …

Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review.

RA Mahumud, K Alam, SA Keramat, GM Ormsby… - PLoS …, 2020 - search.ebscohost.com
Abstract Introduction: The World Health Organization (WHO) recommends that human
papillomavirus (HPV) vaccination programs are established to be cost-effective before …

Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review

RA Mahumud, K Alam, SA Keramat, GM Ormsby… - PLOS …, 2020 - econpapers.repec.org
Introduction: The World Health Organization (WHO) recommends that human papillomavirus
(HPV) vaccination programs are established to be cost-effective before implementation …

Cost-effectiveness evaluations of the 9-valent human papillomavirus (HPV) vaccine: evidence from a systematic review

RA Mahumud, K Alam, SA Keramat… - PLoS …, 2020 - researchdirect.westernsydney.edu …
Abstract Introduction: The World Health Organization (WHO) recommends that human
papillomavirus (HPV) vaccination programs are established to be cost-effective before …
[PDF] core.ac.uk

[PDF][PDF] Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review

RA Mahumud, K Alam, SA Keramat, GM Ormsby… - PLoS ONE, 2020 - core.ac.uk
The World Health Organization (WHO) recommends that human papillomavirus (HPV)
vaccination programs are established to be cost-effective before implementation. WHO …

Cost-effectiveness evaluations of the 9-valent human papillomavirus (HPV) vaccine: evidence from a systematic review.

RA Mahumud, K Alam, SA Keramat, GM Ormsby… - 2020 - cabidigitallibrary.org
Abstract Introduction: The World Health Organization (WHO) recommends that human
papillomavirus (HPV) vaccination programs are established to be cost-effective before …
[PDF] researchgate.net

[PDF][PDF] Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review

RA Mahumud, K Alam, SA Keramat, GM Ormsby… - PLoS ONE, 2020 - researchgate.net
The World Health Organization (WHO) recommends that human papillomavirus (HPV)
vaccination programs are established to be cost-effective before implementation. WHO …
[HTML] nih.gov

[HTML][HTML] Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review

RA Mahumud, K Alam, SA Keramat, GM Ormsby… - PLoS ONE, 2020 - ncbi.nlm.nih.gov
Methods The literature search covering a period of January 2000 to 31 July 2019 was
conducted in PubMed and Scopus bibliographic databases. A combined checklist (ie, WHO …

[引用][C] Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review

RA Mahumud, K Alam, SA Keramat, GM Ormsby… - PLoS …, 2020 - ui.adsabs.harvard.edu
Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine:
Evidence from a systematic review - NASA/ADS Now on home page ads icon ads Enable …